Pseudohypoaldosteronism Differential Diagnoses

  • Author: Alicia Diaz-Thomas, MD, MPH; Chief Editor: Stephen Kemp, MD, PhD   more...
 
Updated: May 16, 2012
 
 

Diagnostic Considerations

In addition to the conditions listed in the differential diagnosis, other problems to be considered include the following:

  • Addison disease
  • Chronic renal failure
  • Isolated hypoaldosteronism
  • Nephronophthisis
  • Obstructive uropathy[12]
  • Salt-wasting nephropathies

Differential Diagnoses

Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Alicia Diaz-Thomas, MD, MPH  Assistant Professor of Pediatrics, University of Tennessee Health Science Center, Memphis

Alicia Diaz-Thomas, MD, MPH is a member of the following medical societies: American Academy of Clinical Endocrinology, Endocrine Society, and Tennessee Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Jose F Pascual-y-Baralt, MD  Chief, Division of Pediatric Nephrology, San Antonio Military Pediatric Center; Clinical Professor, Department of Pediatrics, University of Texas Health Science Campus

Jose F Pascual-y-Baralt, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Nephrology, American Society of Pediatric Nephrology, Association of Military Surgeons of the US, and International Society of Nephrology

Disclosure: Nothing to disclose.

Chief Editor

Stephen Kemp, MD, PhD  Professor, Department of Pediatrics, Section of Pediatric Endocrinology, University of Arkansas for Medical Sciences College of Medicine, Arkansas Children's Hospital

Stephen Kemp, MD, PhD is a member of the following medical societies: American Academy of Pediatrics, American Association of Clinical Endocrinologists, American Pediatric Society, Endocrine Society, Phi Beta Kappa, Southern Medical Association, and Southern Society for Pediatric Research

Disclosure: Nothing to disclose.

Additional Contributors

Robert J Ferry Jr, MD, Le Bonheur Chair of Excellence in Endocrinology, Professor and Chief, Division of Pediatric Endocrinology and Metabolism, Department of Pediatrics, University of Tennessee Health Science Center

Robert J Ferry Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Diabetes Association, American Medical Association, Endocrine Society, Pediatric Endocrine Society, Society for Pediatric Research, and Texas Pediatric Society

Disclosure: Nothing to disclose

Lynne Lipton Levitsky, MD Chief, Pediatric Endocrine Unit, Massachusetts General Hospital; Associate Professor of Pediatrics, Harvard Medical School

Lynne Lipton Levitsky, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Diabetes Association, American Pediatric Society, Endocrine Society, Pediatric Endocrine Society, and Society for Pediatric Research

Disclosure: Pfizer Grant/research funds P.I.; Tercica Grant/research funds Other; Eli Lily Grant/research funds PI; NovoNordisk Grant/research funds PI

Arlan L Rosenbloom, MD Adjunct Distinguished Service Professor Emeritus of Pediatrics, University of Florida College of Medicine; Fellow of the American Academy of Pediatrics; Fellow of the American College of Epidemiology

Arlan L Rosenbloom, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Epidemiology, American Pediatric Society, Endocrine Society, Florida Pediatric Society, Pediatric Endocrine Society, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

References
  1. Melzi ML, Guez S, Sersale G, et al. Acute pyelonephritis as a cause of hyponatremia/hyperkalemia in young infants with urinary tract malformations. Pediatr Infect Dis J. Jan 1995;14(1):56-9. [Medline].

  2. Geller DS, Zhang J, Zennaro MC, et al. Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults. J Am Soc Nephrol. 2006;17:1429-1436. [Medline].

  3. Chitayat D, Spirer Z, Ayalon D, Golander A. Pseudohypoaldosteronism in a female infant and her family: diversity of clinical expression and mode of inheritance. Acta Paediatr Scand. Jul 1985;74(4):619-22. [Medline].

  4. Hogg R, Marks J, Marver D, Frolich J. Long-term observation in a patient with pseudohypoaldosteronism. Pediatr Nephrol. 1991;5:205-210. [Medline].

  5. Huang CL, Cha SK, Wang HR, Xie J, Cobb MH. WNKs: protein kinases with a unique kinase domain. Exp Mol Med. 2007;39:565-73. [Medline].

  6. Tobias JD, Brock JW III, Lynch A. Pseudohypoaldosteronism following operative correction of unilateral obstructive nephropathy. Clin Pediatr (Phila). Jun 1995;34(6):327-30. [Medline].

  7. Valimaki M, Pelkonen R, Tikkanem I, Fyhriquist F. Normal renin sensitivity to atrial natriuretic peptide in Gordon's syndrome. Pediatr Nephrol. 1992;6:44-45. [Medline].

  8. Sheridan MB, Fong P, Groman JD, et al. Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome. Hum Mol Genet. 2005;14:3493-3498. [Medline].

  9. Adachi M, Asakura Y, Muroya K, Tajima T, Fujieda K, Kuribayashi E, et al. Increased Na reabsorption via the Na-Cl cotransporter in autosomal recessive pseudohypoaldosteronism. Clin Exp Nephrol. Apr 8 2010;[Medline].

  10. Mansfield TA, Simon DB, Farfel Z, et al. Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet. Jun 1997;16(2):202-5. [Medline].

  11. Chang SS, Grunder S, Hanukoglu A, et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet. Mar 1996;12(3):248-53. [Medline].

  12. Mastrandrea LD, Martin DJ, Springate JE. Clinical and biochemical similarities between reflux/obstructive uropathy and salt-wasting congenital adrenal hyperplasia. Clin Pediatr (Phila). 2005;44:809-812. [Medline].

  13. Perimenis P, Wemeau JL, Vantyghem MC. Hypercalciuria [French]. Ann Endocrinol (Paris). 2005;66:532-539. [Medline].

Previous
Next
 
Renin angiotensin aldosterone system
Table. Characteristics of Primary Pseudohypoaldosteronism (Types I and II)
Details PHA Type I PHA Type II
Renal PHA-I MTOD PHA-I Early Childhood Hyperkalemia PHA-II
SynonymsClassic PHA of infancy, Cheek and Perry syndrome, autosomal dominant PHA-I, subtype 4 RTA IVAutosomal recessive PHA-ISubtype 5 RTA IVAdolescent hyperkalemic syndrome, Spitzer-Weinstein syndrome, subtype 3 RTA IVGordon syndrome, mineralocorticoid-resistant hyperkalemia, chloride shunt syndrome
AgeNewborn period, infancyNewborn period, infancyInfancy, childhoodChildhoodAdulthood
OrgansKidneyKidney, sweat glands, salivary glands, colonKidneyKidneyKidney
GeneticsAutosomal dominant, sporadicAutosomal recessive, sporadicUnknownUnknownAutosomal dominant, sporadic
MechanismHeterozygous MLR mutations (possible)Defective Na transport in organs that contain ENaCMaturation disorder in the number or function of aldosterone receptorsChloride shuntChloride shunt
Serum potassiumHighHighHighHighHigh
AcidosisPresentPresentPresentPresentPresent
Serum sodiumNormal or lowNormal or lowNormalNormalNormal
PRA*HighHighNormal or highNormal or lowLow
AldosteroneHighHighNormal or highNormal or lowLow
Blood volumeNormovolemia, hypovolemiaNormovolemia, hypovolemiaNormovolemiaHypervolemiaHypervolemia
Blood pressureNormal or lowNormal or lowNormal or lowNormal or lowNormal or low
GFRNormalNormalNormalNormalNormal
Salt wastingRenalRenal, sweat or salivary glands, colonAbsentAbsentAbsent
HypercalciuriaPresent or absentAbsentAbsentPresentPresent
TherapyNa supplementation, K-binding resinsHigh-Na, low-K diet, K-binding resins, hydrochlorothiazideNa bicarbonate, K-binding resinsDietary Na restriction, hydrochlorothiazideDietary Na restriction, hydrochlorothiazide
PrognosisOutgrow by age 2 yLifelong therapyOutgrow by age 5 yLifelong therapyLifelong therapy
*Plasma renin activity.



ENaC = epithelial sodium channel; GFR = glomerular filtration rate; MLR = mineralocorticoid receptor gene; PHA = pseudohypoaldosteronism; RTA = renal tubular acidosis.



Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.